Search research articles
Contact Us
Filters
Showing results (51-60 of 303) with videos related to
Page
of 31
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 22, 2006
Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment
Ronald J Bosch, Rui Wang, Florin Vaida, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 7, 2003
Viral dynamics and their relations to baseline factors and longer term virologic responses in treatment-naive HIV-1-infected patients receiving abacavir in combination with HIV-1 protease inhibitors
Hulin Wu, John Mellors, Ping Ruan, et al.
Plos One
|
March 19, 2013
Decreased IL-7 responsiveness is related to oxidative stress in HIV disease
Magdalina Kalinowska, Douglas A Bazdar, Michael M Lederman, et al.
The Journal of Infectious Diseases
|
January 29, 2003
Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients
Benigno Rodriguez, Ian Woolley, Michael M Lederman, et al.
Current Opinion in HIV and AIDS
|
April 18, 2009
Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption
Michael M Lederman, Adam Penn-Nicholson, Shelley F Stone, et al.
Scientific Reports
|
October 29, 2020
Author Correction: A System of Cytokines Encapsulated in ExtraCellular Vesicles
Wendy Fitzgerald, Michael L Freeman, Michael M Lederman, et al.
Retrovirology
|
December 20, 2008
Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection
Michael M Lederman, Robin Jump, Heather A Pilch-Cooper, et al.
Scientific Reports
|
June 14, 2018
A System of Cytokines Encapsulated in ExtraCellular Vesicles
Wendy Fitzgerald, Michael L Freeman, Michael M Lederman, et al.
Plos One
|
July 16, 2011
Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use
Rebecca Nedellec, Mia Coetzer, Michael M Lederman, et al.
Journal of Virology
|
March 26, 2010
"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance
Rebecca Nedellec, Mia Coetzer, Michael M Lederman, et al.
Page
of 31
Search research articles
Search
Showing results (51-60 of 303) with videos related to
Sort By:
Page
of 31
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 22, 2006
Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment
Ronald J Bosch, Rui Wang, Florin Vaida, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 7, 2003
Viral dynamics and their relations to baseline factors and longer term virologic responses in treatment-naive HIV-1-infected patients receiving abacavir in combination with HIV-1 protease inhibitors
Hulin Wu, John Mellors, Ping Ruan, et al.
Plos One
|
March 19, 2013
Decreased IL-7 responsiveness is related to oxidative stress in HIV disease
Magdalina Kalinowska, Douglas A Bazdar, Michael M Lederman, et al.
The Journal of Infectious Diseases
|
January 29, 2003
Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients
Benigno Rodriguez, Ian Woolley, Michael M Lederman, et al.
Current Opinion in HIV and AIDS
|
April 18, 2009
Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption
Michael M Lederman, Adam Penn-Nicholson, Shelley F Stone, et al.
Scientific Reports
|
October 29, 2020
Author Correction: A System of Cytokines Encapsulated in ExtraCellular Vesicles
Wendy Fitzgerald, Michael L Freeman, Michael M Lederman, et al.
Retrovirology
|
December 20, 2008
Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection
Michael M Lederman, Robin Jump, Heather A Pilch-Cooper, et al.
Scientific Reports
|
June 14, 2018
A System of Cytokines Encapsulated in ExtraCellular Vesicles
Wendy Fitzgerald, Michael L Freeman, Michael M Lederman, et al.
Plos One
|
July 16, 2011
Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use
Rebecca Nedellec, Mia Coetzer, Michael M Lederman, et al.
Journal of Virology
|
March 26, 2010
"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance
Rebecca Nedellec, Mia Coetzer, Michael M Lederman, et al.
Page
of 31